This inventor holds 5 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 1 EPO patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2009-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2020
Title: **Inventor Spotlight: Noriyuki Kamei**
Introduction
Noriyuki Kamei is a notable inventor based in Kyoto, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of five patents, Kamei has made strides in medicinal chemistry, particularly concerning compounds with therapeutic potential.
Latest Patents
Kamei's latest patents include innovative methodologies for the production of complex chemical compounds. One of his key inventions is a method for producing (R)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2H)-yl)methyl]imidazolidine-2,4-dione. This method involves a step for isolating an isomer from a mixture and subsequently obtaining the desired compound by removing specific functional groups. Additionally, he holds a patent related to a pyridone derivative and its use in pharmaceuticals, emphasizing the significance of new agents in medical therapies.
Career Highlights
Noriyuki Kamei is affiliated with Kaken Pharmaceutical Company, Ltd., where he utilizes his expertise in drug development and chemical synthesis. His work has not only advanced the understanding of specific compounds but has also contributed to the broader pharmaceutical landscape. The impact of his inventions is profound, particularly in the development of targeted medications.
Collaborations
Throughout his career, Kamei has worked alongside talented colleagues such as Yoshitake Sumikawa and Daigo Kamimura. These collaborations have enabled a synergy of ideas and innovations, enhancing the quality and applicability of their research outcomes.
Conclusion
Noriyuki Kamei stands out as a prominent figure in the realm of pharmaceutical inventions. His dedication to advancing medicinal chemistry through innovative methodologies has resulted in significant patents that hold promise for future therapies. His contributions reflect a commitment to enhancing healthcare through science and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
